Alto Neuroscience Inc (NYSE:ANRO)
$ 25.3 +0.39 (+1.57%) Market Cap: 887.88 Mil Enterprise Value: 647.33 Mil PE Ratio: 0 PB Ratio: 3.65 GF Score: 12/100

Alto Neuroscience Inc at Bank of America Global Healthcare Conference Transcript

May 13, 2026 / 12:15 AM GMT
Release Date Price: $23.59 (+3.24%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ANRO.N - Alto Neuroscience Inc
Alto Neuroscience Inc at Bank of America Global Healthcare Conference
May 14, 2026 / 12:15AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Founder and CEO of Alto Neuroscience.

Thank you for having us at the B of A conference. I want to take you through the story, focusing really on Alto 207, one of the most important programs in our pipeline.

Those are the forward-looking statements, just to kind of orient.

How to think about ALTO. Our goal is really to establish, to create highly effective new treatments for psychiatric disorders using tools like biomarkers to identify patients with distinct biology that map onto distinct mechanisms of actions of drugs, and to understand the biology to drive to new approaches that really have evidence of unique or outsized efficacy. We address broad populations, depression,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot